Premium
Axsome Therapeutics Inc (1AXSM)
BIT
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Mark ColemanIndependent Lead Director | -17,54k | 4,02M | Automatic Disposition | 223,39 - 233,46 | 433,46k | -3,89% |
| 2026-05-04 | Mr. Mark L. JacobsonCOO | -4,75k | 1,02M | Derivative Exercise and Sale | 12,95 - 228,18 | 0,00 | - |
| 2026-04-22 | Mr. Ari MaizelChief Commercial Officer | -7,50k | 837,68k | Derivative Exercise and Sale | 70,73 - 182,42 | 0,00 | - |
| 2026-02-26 | Dr. Mark ColemanIndependent Lead Director | -25,00k | 4,03M | Automatic Disposition | 161,11 | 451,00k | -5,25% |
| 2026-02-26 | Mr. Mark L. JacobsonCOO | -35,38k | 5,63M | Derivative Exercise and Sale | 2,85 - 161,88 | 0,00 | - |
| 2026-02-23 | Dr. Mark ColemanIndependent Lead Director | 6,25k | 30,94k | Derivative Exercise and Retained Stock | 4,95 | 476,00k | 1,33% |
| 2026-02-20 | Dr. Mark ColemanIndependent Lead Director | 12,49k | 61,80k | Derivative Exercise and Retained Stock | 4,95 | 469,75k | 2,73% |
| 2026-02-10 | Dr. Mark ColemanIndependent Lead Director | 5,19k | 41,65k | Derivative Exercise and Retained Stock | 8,02 | 457,26k | 1,15% |
| 2026-02-02 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -32,41k | 5,76M | Derivative Exercise and Sale | 8,02 - 185,60 | 7,23k | - |
| 2026-01-21 | Mr. Ari MaizelChief Commercial Officer | -7,50k | 852,83k | Derivative Exercise and Sale | 70,73 - 184,44 | 0,00 | - |
| 2026-01-22 | Mr. Nick PizzieCFO | -12,00k | 2,21M | Derivative Exercise and Sale | 3,50 - 187,92 | 43,08k | - |
| 2026-01-05 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -139,41k | 22,76M | Derivative Exercise and Sale | 8,02 - 172,33 | 7,23k | - |
| 2025-12-31 | Mr. Mark E. SaadIndependent Director | -37,58k | 6,00M | Derivative Exercise and Sale | 4,95 - 165,18 | 10,30k | - |
| 2025-12-02 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -79,97k | 11,01M | Derivative Exercise and Sale | 8,02 - 148,18 | 7,23k | - |
| 2025-11-03 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -163,94k | 20,50M | Derivative Exercise and Sale | 8,02 - 134,49 | 7,23k | - |
| 2025-10-06 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -45,38k | 5,05M | Derivative Exercise and Sale | 8,02 - 120,17 | 7,23k | - |
| 2025-09-22 | Mr. Mark L. JacobsonCOO | -10,00k | 1,13M | Derivative Exercise and Sale | 2,85 - 115,96 | 0,00 | - |
| 2025-09-16 | Mr. Mark L. JacobsonCOO | -40,00k | 4,37M | Derivative Exercise and Sale | 4,85 - 114,23 | 0,00 | - |
| 2025-09-16 | Mr. Mark L. JacobsonCOO | -5,78k | 671,93k | Automatic Disposition | 116,19 | 0,00 | -100,00% |
| 2025-09-12 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -62,88k | 6,86M | Derivative Exercise and Sale | 8,02 - 118,96 | 7,23k | - |
| 2025-09-08 | Dr. Mark ColemanIndependent Lead Director | 1,58k | 200,47k | Achat | 127,20 - 127,40 | 452,07k | 0,35% |
| 2025-09-05 | Mr. Mark E. SaadIndependent Director | -9,13k | 1,06M | Derivative Exercise and Sale | 9,00 - 125,07 | 10,30k | - |
| 2025-09-02 | Dr. Roger A. JeffsIndependent Director | -13,46k | 1,67M | Automatic Disposition | 123,68 | 57,51k | -18,97% |
| 2025-08-27 | Dr. Roger A. JeffsIndependent Director | -60,00k | 7,30M | Automatic Disposition | 121,27 - 122,30 | 70,97k | -45,81% |
| 2025-08-22 | Dr. Roger A. JeffsIndependent Director | -36,69k | 4,41M | Automatic Disposition | 120,03 - 120,08 | 130,97k | -21,88% |
| 2025-06-20 | Mr. Hunter MurdockGeneral Counsel & Secretary | -13,51k | 966,44k | Derivative Exercise and Sale | 29,91 - 102,47 | 0,00 | - |
| 2025-06-16 | Mr. Hunter MurdockGeneral Counsel & Secretary | -22,50k | 1,60M | Derivative Exercise and Sale | 29,91 - 102,42 | 0,00 | - |
| 2025-06-09 | Mr. Mark L. JacobsonCOO | -25,00k | 2,56M | Derivative Exercise and Sale | 8,02 - 110,44 | 5,78k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
